FDA Inspection
Corvus Medical, Inc.Corvus Medical, Inc. – FDA Inspection, Mar 19, 2013
Record Details
This FDA Inspection record concerns Corvus Medical, Inc., with an inspection on March 19, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Corvus Medical, Inc.
- Inspection Date
- March 19, 2013
- Product Type
- Biologics
View Company Profile
ID · 633b32ec-4082-4a42-8d6c-89b1473aa97e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 825199
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
3- 21 CFR 1271.160(a)All core requirements covered in program
- 21 CFR 1271.180(a)Procedures to meet core CTGP
- 21 CFR 1271.320(a)Procedures re complaints
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Corvus Medical, Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| May 23, 2018 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| May 19, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| May 22, 2012 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Corvus Medical, Inc.
- FDA Inspection 1054910 - 2018-05-23
- FDA Inspection 927866 - 2015-05-19
- FDA Inspection 783195 - 2012-05-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.